Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bird Flu”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00783926
What this trial is testing

Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 422
Early research (Phase 1)Study completedNCT00297050
What this trial is testing

Safety and Dose Study of Peramivir for Influenza Treatment

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT00397215
What this trial is testing

Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 437
Not applicableWithdrawnNCT00417560
What this trial is testing

Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses

Who this might be right for
Influenza
Centers for Disease Control and Prevention
Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Early research (Phase 1)Study completedNCT01142362
What this trial is testing

Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults

Who this might be right for
Healthy
Inovio Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT00703053
What this trial is testing

H5N1 Priming and Boosting Strategies

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 505
Testing effectiveness (Phase 2)WithdrawnNCT01045564
What this trial is testing

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Who this might be right for
Influenza
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT06382311
What this trial is testing

Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 991
Testing effectiveness (Phase 2)Study completedNCT00695669
What this trial is testing

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

Who this might be right for
Influenza
GlaxoSmithKline 312
Early research (Phase 1)Study completedNCT01656356
What this trial is testing

Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers

Who this might be right for
Preventive Avian Flu
Mahidol University
Not applicableWithdrawnNCT00640302
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza

Who this might be right for
Pandemic Influenza
Kirby Institute
Early research (Phase 1)Study completedNCT00694213
What this trial is testing

Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)

Who this might be right for
Influenza
Vical 47
Large-scale testing (Phase 3)Study completedNCT00519064
What this trial is testing

Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases

Who this might be right for
Influenza Disease
Novartis Vaccines 361
Testing effectiveness (Phase 2)Study completedNCT03589807
What this trial is testing

2013/2017 H7N9 Prime-Boost Interval

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 180
Early research (Phase 1)Study completedNCT02151344
What this trial is testing

Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT01353534
What this trial is testing

Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine

Who this might be right for
Healthy
Intercell USA, Inc. 276
Large-scale testing (Phase 3)Study completedNCT00848029
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Who this might be right for
Pre-pandemic Influenza Vaccine
Novartis Vaccines 240
Large-scale testing (Phase 3)Study completedNCT00319098
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
GlaxoSmithKline 5,075
Early research (Phase 1)Study completedNCT02335164
What this trial is testing

Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Who this might be right for
Influenza
Vaxine Pty Ltd 270
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation